Marshall Wace North America’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
$6.29M Buy
14,806
+13,353
+919% +$5.67M 0.03% 449
2021
Q2
$522K Buy
+1,453
New +$522K ﹤0.01% 1121
2020
Q1
Sell
-1,678
Closed -$252K 1640
2019
Q4
$252K Sell
1,678
-4,593
-73% -$690K ﹤0.01% 925
2019
Q3
$889K Buy
+6,271
New +$889K 0.01% 718
2019
Q1
Sell
-7,584
Closed -$743K 1947
2018
Q4
$743K Buy
+7,584
New +$743K 0.01% 682
2018
Q3
Sell
-24,201
Closed -$2.4M 1412
2018
Q2
$2.4M Buy
24,201
+6,564
+37% +$652K 0.01% 719
2018
Q1
$1.56M Buy
+17,637
New +$1.56M 0.01% 878
2017
Q4
Sell
-50,240
Closed -$4.82M 1639
2017
Q3
$4.82M Sell
50,240
-95,320
-65% -$9.15M 0.03% 557
2017
Q2
$13.8M Buy
145,560
+21,369
+17% +$2.03M 0.1% 249
2017
Q1
$10.2M Buy
+124,191
New +$10.2M 0.08% 264